Laboratory Corporation of America
Laboratory Corporation of America was paid $11.66M by Medicaid between Jul 2019 and Dec 2024, across 30 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 28% of everything it billed.
LAKEWOOD, CO 80226
Next to other Clinical Medical Laboratory providers in Colorado
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 16,905 | $673K | |
| 2020 | 29,105 | $1.23M | |
| 2021 | 110,839 | $4.29M | |
| 2022 | 73,999 | $2.48M | |
| 2023 | 62,292 | $1.88M | |
| 2024incomplete | 36,312 | $1.10M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 28% | 50,624 | 44,615 | $3.30M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 15% | 55,779 | 52,473 | $1.71M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 14% | 77,175 | 72,102 | $1.62M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12% | 18,804 | 17,130 | $1.36M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.2% | 31,438 | 28,636 | $953K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.2% | 31,417 | 28,615 | $953K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.7% | 10,581 | 9,912 | $316K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.5% | 14,064 | 12,509 | $290K |
| 88342 | 1.7% | 3,144 | 2,868 | $197K | |
| 88141 | 1.0% | 8,098 | 7,555 | $119K | |
| 87625 | <1% | 3,478 | 3,227 | $116K | |
| 88142 | <1% | 5,588 | 5,270 | $92K |
18 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 349 | $81K |
| 88304 | <1% | 1,660 | $66K | |
| 87512 | <1% | 1,231 | $58K | |
| 87480 | <1% | 3,048 | $53K | |
| 87660 | <1% | 3,030 | $53K | |
| 87510 | <1% | 3,043 | $53K | |
| 88307 | <1% | 437 | $48K | |
| 88341 | <1% | 501 | $46K | |
| 87481 | <1% | 975 | $42K | |
| 88312 | <1% | 853 | $40K | |
| 85060 | <1% | 2,128 | $35K | |
| 87799 | <1% | 363 | $27K | |
| 87150 | <1% | 432 | $15K | |
| 88112 | <1% | 242 | $11K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 463 | $6K |
| 87081 | <1% | 430 | $3K | |
| 87529 | <1% | 51 | $2K | |
| 88313 | <1% | 26 | $374.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.